Jérôme Harambat

Summary

Affiliation: CHU de Bordeaux
Country: France

Publications

  1. ncbi Prediction of steroid-sparing agent use in childhood idiopathic nephrotic syndrome
    Jérôme Harambat
    Service de Pediatrie, Centre de référence Maladies Rénales Rares du Sud Ouest, Centre Hospitalier Universitaire de Bordeaux, Place Amelie Raba Leon, 33076, Bordeaux, France
    Pediatr Nephrol 28:631-8. 2013
  2. ncbi Adenine phosphoribosyltransferase deficiency in children
    Jérôme Harambat
    Service de Pediatrie, Centre Hospitalier Universitaire de Bordeaux, Centre de référence Maladies Rénales Rares du Sud Ouest, Bordeaux, France
    Pediatr Nephrol 27:571-9. 2012
  3. ncbi Successful treatment with rituximab for acute refractory thrombotic thrombocytopenic purpura related to acquired ADAMTS13 deficiency: a pediatric report and literature review
    Jérôme Harambat
    Service de Pédiatrie Hôpital Pellegrin Enfants, CHU de Bordeaux and Université de Bordeaux, Bordeaux, France
    Pediatr Crit Care Med 12:e90-3. 2011
  4. ncbi Severe transient ADAMTS13 deficiency in pneumococcal-associated hemolytic uremic syndrome
    Sybille Pelras
    Service de Pediatrie, Hôpital Pellegrin Enfants, Centre Hospitalier Universitaire, Bordeaux, France
    Pediatr Nephrol 26:631-5. 2011
  5. ncbi Effect of conservative treatment on the renal outcome of children with primary hyperoxaluria type 1
    Sonia Fargue
    Service de Pediatrie, Centre de Référence des Maladies Rénales Rares, Hospices Civils de Lyon and Université Lyon 1, Lyon, France
    Kidney Int 76:767-73. 2009
  6. ncbi Long-term effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome
    Benoit Cammas
    Centre Hospitalier Universitaire de Bordeaux, Service de Pediatrie, Centre de référence Maladies Rénales Rares du Sud Ouest, Bordeaux, France
    Nephrol Dial Transplant 26:178-84. 2011
  7. ncbi Primary hyperoxaluria
    Jérôme Harambat
    Service de Pediatrie, Centre de référence Maladies Rénales Rares du Sud Ouest, Centre Hospitalier Universitaire de Bordeaux, 33076 Bordeaux, France
    Int J Nephrol 2011:864580. 2011
  8. ncbi Renal impairment in children with cystic fibrosis
    Annick Andrieux
    CHU de Bordeaux, Centre de Ressources et de Compétences de la Mucoviscidose pédiatrique, Hôpital Pellegrin Enfants, Bordeaux, France
    J Cyst Fibros 9:263-8. 2010
  9. ncbi Maximizing growth in children after renal transplantation
    Pierre Cochat
    Service de Pediatrie, Centre de Référence des Maladies Rénales Rares and Inserm U820, Hospices Civils de Lyon and Université de Lyon, Lyon, France
    Transplantation 88:1321-2. 2009
  10. ncbi Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome
    Jérôme Harambat
    Service de Pediatrie, Centre de Référence des Maladies Rénales Rares du Sud Ouest, Centre Hospitalier Universitaire, Bordeaux, France
    Kidney Int 77:443-9. 2010

Collaborators

Detail Information

Publications12

  1. ncbi Prediction of steroid-sparing agent use in childhood idiopathic nephrotic syndrome
    Jérôme Harambat
    Service de Pediatrie, Centre de référence Maladies Rénales Rares du Sud Ouest, Centre Hospitalier Universitaire de Bordeaux, Place Amelie Raba Leon, 33076, Bordeaux, France
    Pediatr Nephrol 28:631-8. 2013
    ..The aim of this study was to identify predictors of the need for SSA and derive a predictive model...
  2. ncbi Adenine phosphoribosyltransferase deficiency in children
    Jérôme Harambat
    Service de Pediatrie, Centre Hospitalier Universitaire de Bordeaux, Centre de référence Maladies Rénales Rares du Sud Ouest, Bordeaux, France
    Pediatr Nephrol 27:571-9. 2012
    ..Based on these results, we conclude that an excellent outcome can be achieved in children with APRT deficiency who receive the proper treatment...
  3. ncbi Successful treatment with rituximab for acute refractory thrombotic thrombocytopenic purpura related to acquired ADAMTS13 deficiency: a pediatric report and literature review
    Jérôme Harambat
    Service de Pédiatrie Hôpital Pellegrin Enfants, CHU de Bordeaux and Université de Bordeaux, Bordeaux, France
    Pediatr Crit Care Med 12:e90-3. 2011
    ..To report the case of a child with severe autoimmune thrombotic thrombocytopenic purpura (TTP) resistant to plasma exchange and steroids who was successfully treated with rituximab...
  4. ncbi Severe transient ADAMTS13 deficiency in pneumococcal-associated hemolytic uremic syndrome
    Sybille Pelras
    Service de Pediatrie, Hôpital Pellegrin Enfants, Centre Hospitalier Universitaire, Bordeaux, France
    Pediatr Nephrol 26:631-5. 2011
    ..Severe ADAMTS13 deficiency appears to be a manifestation of transient endothelial cell injury in the context of severe sepsis, including invasive p-HUS. The choice of appropriate therapy should not be based on this finding...
  5. ncbi Effect of conservative treatment on the renal outcome of children with primary hyperoxaluria type 1
    Sonia Fargue
    Service de Pediatrie, Centre de Référence des Maladies Rénales Rares, Hospices Civils de Lyon and Université Lyon 1, Lyon, France
    Kidney Int 76:767-73. 2009
    ..7 per year. Our study strongly suggests that early and aggressive conservative management may preserve renal function of compliant children with this disorder, thereby avoiding dialysis and postponing transplantation...
  6. ncbi Long-term effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome
    Benoit Cammas
    Centre Hospitalier Universitaire de Bordeaux, Service de Pediatrie, Centre de référence Maladies Rénales Rares du Sud Ouest, Bordeaux, France
    Nephrol Dial Transplant 26:178-84. 2011
    ..Little is known about prognostic factors in SDNS and FRNS treated by CYP. The objectives of this study are to determine long-term outcomes and factors associated with sustained remission in these patients...
  7. ncbi Primary hyperoxaluria
    Jérôme Harambat
    Service de Pediatrie, Centre de référence Maladies Rénales Rares du Sud Ouest, Centre Hospitalier Universitaire de Bordeaux, 33076 Bordeaux, France
    Int J Nephrol 2011:864580. 2011
    ..In end-stage renal disease patients, the best outcomes have been achieved with combined liver-kidney transplantation which corrects the enzyme defect...
  8. ncbi Renal impairment in children with cystic fibrosis
    Annick Andrieux
    CHU de Bordeaux, Centre de Ressources et de Compétences de la Mucoviscidose pédiatrique, Hôpital Pellegrin Enfants, Bordeaux, France
    J Cyst Fibros 9:263-8. 2010
    ..Due to the improvement in life expectancy in cystic fibrosis (CF), co-morbidities such as renal function impairment may be more frequent...
  9. ncbi Maximizing growth in children after renal transplantation
    Pierre Cochat
    Service de Pediatrie, Centre de Référence des Maladies Rénales Rares and Inserm U820, Hospices Civils de Lyon and Université de Lyon, Lyon, France
    Transplantation 88:1321-2. 2009
    ....
  10. ncbi Genotype-phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome
    Jérôme Harambat
    Service de Pediatrie, Centre de Référence des Maladies Rénales Rares du Sud Ouest, Centre Hospitalier Universitaire, Bordeaux, France
    Kidney Int 77:443-9. 2010
    ..Our results underscore the severe prognosis of primary hyperoxaluria type 1 and the necessity for early diagnosis and treatment, as well as confirm a better prognosis of the p.Gly170Arg mutation...
  11. ncbi Invasive fungal disease in PICU: epidemiology and risk factors
    Olivier Brissaud
    Pediatric and Neonatal Intensive Care Unit, The Children s Hospital of Bordeaux, Place Amelie Raba Leon, 33076 Bordeaux Cedex, France
    Ann Intensive Care 2:6. 2012
    ..In children, the mortality rate for invasive aspergillosis is 2.5 to 3.5 higher than for invasive candidiasis (respectively 70% vs. 20% and 30%)...
  12. ncbi [Phenotypic heterogeneity of TCF2's gene mutation coding for HNF-1 beta in a single family]
    Claire Rigothier
    Services de néphrologie et de pédiatrie, Centre de Référence des Maladies Rénales Rares du Sud Ouest, Universite de Bordeaux, CHU de Bordeaux, Bordeaux, France
    Nephrol Ther 5:287-91. 2009
    ....